Terrence C. Kearney, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 10,000 shares at $350.00 ($3.5M) on 2023-08-10, disclosed to the SEC on 2023-08-14.
Scheduled sale ($3.5M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VRTX | SELL | 2015-04-29 | $8.8M | — | Filing → |
| HSP | SELL | 2010-12-17 | $10.3M | — | Filing → |
| HSP | SELL | 2010-10-25 | $1.7M | — | Filing → |